Clinical Immunoanalyzer Markets

1. Overview

• 1.1 Objectives
• 1.2 Methodology
• 1.3 TriMark Publications Report Research and Data Acquisition Structure
• 1.4 Scope
• 1.5 Executive Summary

2. IVD Clinical Immunoanalyzer Market

• 2.1 Introduction

3. IVD Clinical Immunoanalyzer Market Analysis

• 3.1 Markets
  • 3.1.1 Global Markets
  • 3.1.2 Global Drivers of Clinical Immunoanalyzer Testing
  • 3.1.3 Global Outlook
  • 3.1.4 U.S. Market
  • 3.1.5 European IVD Market
    • 3.1.5.1 German Clinical Immunoanalyzer Diagnostic Markets
    • 3.1.5.2 U.K. Clinical Immunoanalyzer Testing Diagnostic Market
    • 3.1.5.3 French Clinical Laboratory Diagnostic Testing Market
    • 3.1.5.4 Italian Clinical Immunochemistry Diagnostic Market
    • 3.1.5.5 Spanish Immunoanalyzer Market
    • 3.1.5.6 Finnish Immunoanalyzer Market
    • 3.1.5.7 Belgian Immunoanalyzer Market
    • 3.1.5.8 Swiss Immunoanalyzer Market
    • 3.1.5.9 Dutch Immunoanalyzer Market
    • 3.1.5.10 Portugese Immunoanalyzer Market
    • 3.1.5.11 Austrian Immunoanalyzer Market
    • 3.1.5.12 Greek Immunoanalyzer Market
    • 3.1.5.13 Polish Immunoanalyzer Market
    • 3.1.5.14 Romanian Immunoanalyzer Market
  • 3.1.6 Indian Clinical Analyzer Diagnostic Market
    • 3.1.6.1 India' s in vitro Diagnostic Testing Industry
  • 3.1.7 Japanese Clinical Immunoanalyzer Testing Market
  • 3.1.8 Country Clinical Analyzer Smaller Markets
    • 3.1.8.1 China Clinical Analyzer Market
    • 3.1.8.2 Canada Clinical Analyzer Market
    • 3.1.8.3 Brazil Clinical Analyzer Market
    • 3.1.8.4 Turkey Clinical Immunoanalyzer Market
    • 3.1.8.5 Australia Clinical Analyzer Market
    • 3.1.8.6 Rest of the World Clinical Analyzer Testing Market
  • 3.1.9 Overview of Asian Healthcare Market
    • 3.1.9.1 Singapore
    • 3.1.9.2 Malaysia
    • 3.1.9.3 Thailand
    • 3.1.9.4 Indonesia
    • 3.1.9.5 Philippines
    • 3.1.9.6 South Korea
    • 3.1.9.7 India
    • 3.1.9.8 Hong Kong
    • 3.1.9.9 Taiwan
• 3.2 Clinical Immunoanalyzer Sector
  • 3.2.1 Industry-Served Markets
  • 3.2.2 Industry Players
    • 3.2.2.1 Manufacturing Companies
  • 3.2.3 Market Specialization
  • 3.2.4 Revenue and Reimbursement
  • 3.2.5 Companies
• 3.3 Outlook for Clinical Immunoanalyzer Testing
  • 3.3.1 Long-Term Changes
  • 3.3.2 Market Drivers
  • 3.3.3 Limits to Growth
  • 3.3.4 Hot Sectors in IVD Market
  • 3.3.5 Key Technologies
  • 3.3.6 Analyzer Integration Chemistry/Immunoassay
  • 3.3.7 Conclusion

4. Clinical Immunoanalyzer Instrument Market by Sector

• 4.1 Market Analysis: Size, Growth, Share and Competitors
  • 4.1.1 Immunochemistry Analyzers
  • 4.1.2 Large-Volume Immunochemistry Analyzers
    • 4.1.2.1 Abbott Diagnostics
    • 4.1.2.2 Siemens Medical Solutions Diagnostics
    • 4.1.2.3 Beckman Coulter
    • 4.1.2.4 Dade Behring (Siemens)
    • 4.1.2.5 Diagnostics Products Corporation (Siemens)
    • 4.1.2.6 Olympus
    • 4.1.2.7 Ortho-Clinical Diagnostics
    • 4.1.2.8 Roche Diagnostics
    • 4.1.2.9 Tosoh Bioscience
  • 4.1.3 Batch-Type Immunoassay Analyzers
    • 4.1.3.1 Bio-Rad
    • 4.1.3.2 Dade Behring
    • 4.1.3.3 Diamedix
    • 4.1.3.4 Tosoh
  • 4.1.4 Small-Volume to Mid-Volume Immunoassay Analyzers
    • 4.1.4.1 Awareness Technology
    • 4.1.4.2 Siemens Diagnostics
    • 4.1.4.3 Beckman Coulter
    • 4.1.4.4 bioMerieux
    • 4.1.4.5 Dade Behring (Siemens)
    • 4.1.4.6 Randox
      • 4.1.4.6.1 Randox Laboratories
    • 4.1.4.7 Tosoh
  • 4.1.5 Other Immunoassay Analyzers
    • 4.1.5.1 Inverness Medical Professional Diagnostics
    • 4.1.5.2 Hycor BioMedical
    • 4.1.5.3 Phadia
    • 4.1.5.4 Trinity Biotech
    • 4.1.5.5 Diasorin
    • 4.1.5.6 Grifols
    • 4.1.5.7 Bio-Rad
    • 4.1.5.8 SFRI Diagnostics
    • 4.1.5.9 Qualigen
    • 4.1.5.10 PerkinElmer Life and Analytical Sciences
    • 4.1.5.11 Innotrac Diagnostics
    • 4.1.5.12 Tecan

5. Important Technology Trends

• 5.1 Technology Innovations in Immunoassay Testing
• 5.2 Immunoassay Detection Technology Platforms
  • 5.2.1 Fluorescence Detection
  • 5.2.2 Chemiluminescence Detection
• 5.3 The New Paradigm
• 5.4 Consolidated Workstations
• 5.5 Automation in the Laboratory in Response to Labor Shortages
• 5.6 Laboratory Information System (LIS)
• 5.7 Biosensor Technology
• 5.8 Data Management Issues
  • 5.8.1 Wireless LANs
  • 5.8.2 Data and Workflow Management Systems
  • 5.8.3 Beckman Central Command
  • 5.8.4 Advances in Information Management
  • 5.8.5 Connectivity Platforms
  • 5.8.6 DataLink Data Management System
  • 5.8.7 LabPortal.com
  • 5.8.8 LifeScan Electronic Data Interfaces
  • 5.8.9 Technical Problems of Connectivity
  • 5.8.10 Web-Based Data Interface and Internet Connectivity
  • 5.8.11 HIT Competition
  • 5.8.12 FDA-Required Software Verification
  • 5.8.13 Advantages of Connectivity
  • 5.8.14 Technologies for Internet-based Remote Architecture
  • 5.8.15 Abbott Multitiered Internet System

6. Business Trends in Clinical Immunoanalyzer Sector

• 6.1 Key Developments
• 6.2 Sector Consolidation
• 6.3 Diagnostic Testing Growth Trends
• 6.4 Reagents and Hardware Business in Japan
• 6.5 New Products
• 6.6 Acquisitions, License Agreements, Internal Developments and Partnerships
• 6.7 Product Testing Depth in Clinical Immunoanalyzer Testing
• 6.8 Government Regulations
  • 6.8.1 U.S. Government Regulations
    • 6.8.1.1 Importing Medical Devices into the U.S.
    • 6.8.1.2 Exporting Medical Devices from the U.S.
  • 6.8.2 U.K. Regulations
  • 6.8.3 E.U. Regulations
  • 6.8.4 Japanese Regulations
  • 6.8.5 Korean Regulations
• 6.9 Increased Market Penetration
• 6.10 Costs of Doing Business in Europe
• 6.11 Drivers of European Diagnostics Testing
• 6.12 European Reimbursement Practices
• 6.13 Cost Containment in Europe
• 6.14 Medicare Spending Trends/Medicare Part B Spending Trends

7. Company Profiles

• 7.1 Abbott Diagnostics
• 7.2 Bayer Healthcare
• 7.3 Beckman Coulter
• 7.4 bioMerieux
• 7.5 Dade Behring
• 7.6 Bio-Rad Laboratories
• 7.7 Olympus
• 7.8 Ortho-Clinical Diagnostics
• 7.9 Phadia
• 7.10 Randox Laboratories
• 7.11 Roche Diagnostics
• 7.12 Tosoh
• 7.13 Siemens

8. Clinical Immunoanalyzer Testing Sector: Trends and Forecasts

• 8.1 Automated Intrument Platforms Evolution
• 8.2 Reagents and Supplies Market for Clinical Lab Instruments
• 8.3 Bar Code Reading
• 8.4 Measurement and Detection for Immunoassay Analyzers
• 8.5 Robotics
• 8.6 Move Away from Central Laboratory
• 8.7 Modular Automation
• 8.8 Components of Immunoassay Analyzers
• 8.9 Drivers of Clinical Immunoanalyzer Testing
• 8.10 Confluence of New Technology
• 8.11 New Trends in Clinical Laboratory Testing
  • 8.11.1 Trends in Reimbursement Practices
  • 8.11.2 Managed Care
  • 8.11.3 Changes in Patient Management
  • 8.11.4 Focused Testing
  • 8.11.5 Spending for Clinical Laboratory Testing
  • 8.11.6 Reimbursement Pressure
  • 8.11.7 Multiplexing Technology

9. Product Launches

• 9.1 Immunoassay Analyzer Product Launches
• 9.2 Immunoassay Reagent Product Launches

• Table 2.1: Common Immunoassay Tests
• Table 3.1: The Overall IVD Diagnostic Testing Market Worldwide, 2006
• Table 3.2: Worldwide Distribution of IVD Testing, 2006
• Table 3.3: Global Clinical Immunoassay Revenues, 2000 to 2012
• Table 3.4: Worldwide Distribution of Clinical Immunoassay Testing, 2006
• Table 3.5: U.S. Clinical Laboratory Testing Market, 2003 to 2012
• Table 3.6: U.S. Clinical Laboratory Diagnostic Test Market Segments, 2006
• Table 3.7: U.S. Clinical Laboratory Diagnostic Testing Reagents and Instruments Markets by Analyte, 2006
• Table 3.8: U.S. Clinical Immunoanalyzer Testing Market, 2000 to 2012
• Table 3.9: European Clinical Laboratory Testing IVD Reagents and Instruments Market (Dollars), 2000 to 2012
• Table 3.10: European Clinical Laboratory Testing IVD Reagents and Instruments Market (Euros), 2000 to 2012
• Table 3.11: European Clinical Laboratory Diagnostic Reagents and Instruments Markets by Analyte, 2006
• Table 3.12: European Clinical Laboratory Testing Diagnostics by Country Market Estimates, 2006
• Table 3.13: The European Immunochemistry Market, 2001 to 2012
• Table 3.14: European Immunochemical Reagents and Instruments Markets by Country, 2006
• Table 3.15: German Clinical Laboratory Testing Diagnostics Products Market Sales, 2003 to 2012
• Table 3.16: German Clinical Immunochemistry Testing Diagnostics Products Market Sales, 2006 to 2012
• Table 3.17: UK Clinical Immunochemistry Testing Diagnostics Products Market Sales, 2006 to 2012
• Table 3.18: French Clinical Immunochemistry Testing Diagnostics Products Market Sales, 2006 to 2012
• Table 3.19: Italian Immunochemistry Diagnostics Products Market Sales, 2006 to 2012
• Table 3.20: Spanish Clinical Laboratory Diagnostics Products Market Sales, 2006 to 2012
• Table 3.21: Finnish Clinical Immunoassay Products Market Sales, 2006 to 2012
• Table 3.22: Belgium Clinical Immunoassay Products Market Sales, 2006 to 2012
• Table 3.23: Swiss Clinical Immunoassay Products Market Sales, 2006 to 2012
• Table 3.24: Dutch Clinical Immunoassay Products Market Sales, 2006 to 2012
• Table 3.25: Portugese Clinical Immunoassay Products Market Sales, 2006 to 2012
• Table 3.26: Austrian Clinical Immunoassay Products Market Sales, 2006 to 2012
• Table 3.27: Greek Clinical Immunoassay Products Market Sales, 2006 to 2012
• Table 3.28: Polish Clinical Immunoassay Products Market Sales, 2006 to 2012
• Table 3.29: Romanian Clinical Immunoassay Products Market Sales, 2006 to 2012
• Table 3.30: Indian IVD Market, 2006 to 2012
• Table 3.31: Number of Automated Clinical Labs in India, 2004 to 2012
• Table 3.32: Indian IVD Market (by Sector), 2006
• Table 3.33: IVD Equipment and Reagents Market (by Company) in India, 2004 and 2005
• Table 3.34: Japanese Clinical Immunoanalyzer Testing Market, 2000 to 2008
• Table 3.35: Chinese Clinical Diagnostic Products Market, 2000 to 2008
• Table 3.36: Canadian Clinical Analyzer Testing Market, 2000 to 2008
• Table 3.37: Brazilian Clinical Immunoanalyzer Testing Market, 2000 to 2008
• Table 3.38: Turkish Clinical Analyzer Testing Market, 2000 to 2008
• Table 3.39: Australian Clinical Immunoanalyzer Testing Market, 2000 to 2008
• Table 3.40: ROW Clinical Immunoanalyzer Testing Market, 2000 to 2008
• Table 3.41: Estimated Number of Clinical Laboratories in Latin America
• Table 3.42: Principal Marketers of Automated Clinical Immunoanalyzer Instruments
• Table 4.1: Samples and Sample Handling Features of Centaur CP
• Table 4.2: Large Immunochemistry Analyzers
• Table 4.3: Small- to Mid-Volume Immunoassay Analyzers
• Table 5.1: Wireless LAN Technology Companies
• Table 5.2: Applications for Wireless LAN Technology
• Table 5.3: CAP and JCAHO Requirements for Customized Reporting
• Table 6.1: Hospital Laboratory Share of Part B Medicare Spending, 1996 to 2005
• Table 6.2: Medicare Part B Spending Per Medicare Enrollee, 1998 to 2005
• Table 6.3: Allowed Charges for Top 25 Clinical Laboratory Procedures, 2005
• Table 8.1: Technology Platforms for Analyzer Detection Systems
• Table 8.2: Medicare Billing Guidelines for Multi-Channel Immunoanalyzer Tests

• Figure 3.1: U.S. Revenue for Six Largest IVD Vendors, 2005
• Figure 3.2: U.S. Revenue Change for Six Largest IVD Vendors, 2005
• Figure 6.1: Part B Spending on Clinical Lab Services, 1991 to 2005